Skip to content

Clinical trials

Nephritis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nephritis Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20102
20111
20121
20161
20171
20191
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status3
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
RenJi Hospital2
Tuen Mun Hospital2
Astellas Pharma Inc1
Genzyme, a Sanofi Company1
Human Genome Sciences Inc., a GSK Company1
Nanjing University School of Medicine1
Novartis Pharmaceuticals1
Peking Union Medical College Hospital1
RemeGen Co., Ltd.1
argenx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nephritis12
Lupus Nephritis9
Kidney Diseases5
Glomerulonephritis4
Autoimmune Diseases2
Lupus Erythematosus, Systemic2
Urologic Diseases2
Glomerulonephritis, IGA1
IgA Vasculitis1
Immune System Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.